| Literature DB >> 25089038 |
Gustavo Marçal Schmidt Garcia Moreira1, Paula de Lima Telmo2, Marcelo Mendonça1, Angela Nunes Moreira3, Alan John Alexander McBride1, Carlos James Scaini4, Fabricio Rochedo Conceição5.
Abstract
Toxocariasis is a neglected zoonosis caused by the nematodes Toxocara canis and Toxocara cati. This disease is widespread in many countries, reaching high prevalence independently of the economic conditions. However, the true number of cases of toxocariasis is likely to be underestimated owing to the lack of adequate surveillance programs. Although some diagnostic tests are available, their sensitivity and specificity need to be improved. In addition, treatment options for toxocariasis are limited and are non-specific. Toxocariasis is listed as one of the five most important neglected diseases by the CDC. This review presents recent advances related to the control of toxocariasis, including new immunodiagnostics, therapies, and drug formulations, as well as novel interventions using DNA vaccines, immunomodulators, and probiotics.Entities:
Keywords: Toxocara canis; Toxocara cati; drug modification; immunodiagnostics; probiotics; toxocariasis
Mesh:
Substances:
Year: 2014 PMID: 25089038 DOI: 10.1016/j.pt.2014.07.003
Source DB: PubMed Journal: Trends Parasitol ISSN: 1471-4922